Atlas Trials

Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)

Clinical trial NCT02974504 · COMPLETED

Trial details

NCT number
NCT02974504
Sponsor
Dong-A ST Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type2 Diabetes
Start date
2016-09-01
Primary completion
2018-03-01
Enrollment
207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.